Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Apr;93(4):827–832. doi: 10.1111/j.1476-5381.1988.tb11468.x

Regional myocardial ajmaline concentration and antiarrhythmic activity for ischaemia- and reperfusion-induced arrhythmias in rats.

K Okumura 1, Y Hashimoto 1, M Yasuhara 1, R Hori 1
PMCID: PMC1853889  PMID: 3390652

Abstract

1. Antiarrhythmic actions of ajmaline against ischaemia (left coronary artery occlusion for 15 min) and subsequent reperfusion-induced arrhythmias were investigated in anaesthetized rats. 2. Ajmaline (2 mg kg-1, i.v.) was effective in suppressing ischaemia-induced arrhythmias whether given pre- or post-occlusion. 3. Ajmaline diminished the reperfusion-induced arrhythmias completely when given pre-occlusion but had little effect when given post-occlusion. 4. Reperfusion-induced increases in plasma enzyme activities of lactate dehydrogenase, glutamate-oxaloacetate transaminase and creatine phosphokinase were prevented more effectively when ajmaline was given pre-occlusion rather than post-occlusion. 5. Fifteen min post-occlusion, the ajmaline concentrations in the ischaemic ventricle were 18.42 +/- 1.66 and 1.18 +/- 0.15 micrograms g-1 for pre- and post-occlusion administration, respectively. However, ajmaline concentrations in whole blood and normal ventricle were not significantly different between pre- and post-occlusion administration. 6. We suggest that the beneficial effect of ajmaline against reperfusion-induced arrhythmias is related to the ischaemic myocardial concentration of ajmaline which is markedly affected by the time of drug administration (i.e. pre- and post-occlusion).

Full text

PDF
827

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergey J. L., Nocella K., McCallum J. D. Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine. Eur J Pharmacol. 1982 Jul 9;81(2):205–216. doi: 10.1016/0014-2999(82)90438-1. [DOI] [PubMed] [Google Scholar]
  2. Corbalan R., Verrier R. L., Lown B. Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release. Am Heart J. 1976 Aug;92(2):223–230. doi: 10.1016/s0002-8703(76)80258-x. [DOI] [PubMed] [Google Scholar]
  3. Corr P. B., Witkowski F. X. Arrhythmias associated with reperfusion: basic insights and clinical relevance. J Cardiovasc Pharmacol. 1984;6 (Suppl 6):S903–S909. [PubMed] [Google Scholar]
  4. Crome R., Hearse D. J., Manning A. S. Ischemia- and reperfusion-induced arrhythmias: beneficial actions of nifedipine. J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1249–1256. doi: 10.1097/00005344-198611000-00023. [DOI] [PubMed] [Google Scholar]
  5. Curtis M. J., MacLeod B. A., Walker M. J. Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat. Br J Pharmacol. 1984 Oct;83(2):373–385. doi: 10.1111/j.1476-5381.1984.tb16497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davis R. F., DeBoer L. W., Yasuda T., Rude R. E., Ribeiro L. G., Maroko P. R. Regional myocardial lidocaine concentration determines the antidysrhythmic effect in dogs after coronary artery occlusion. Anesthesiology. 1985 Feb;62(2):155–160. doi: 10.1097/00000542-198502000-00011. [DOI] [PubMed] [Google Scholar]
  7. Hashimoto Y., Hori R., Okumura K., Yasuhara M. Pharmacokinetics and antiarrhythmic activity of ajmaline in rats subjected to coronary artery occlusion. Br J Pharmacol. 1986 May;88(1):71–77. doi: 10.1111/j.1476-5381.1986.tb09472.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hori R., Okumura K., Inui K., Yasuhara M., Yamada K., Sakurai T., Kawai C. Quinidine-induced rise in ajmaline plasma concentration. J Pharm Pharmacol. 1984 Mar;36(3):202–204. doi: 10.1111/j.2042-7158.1984.tb06942.x. [DOI] [PubMed] [Google Scholar]
  9. Iven H. The pharmacokinetics and organ distribution of ajmaline and quindine in the mouse. Naunyn Schmiedebergs Arch Pharmacol. 1977 May;298(1):43–50. doi: 10.1007/BF00510985. [DOI] [PubMed] [Google Scholar]
  10. Kane K. A., Parratt J. R., Williams F. M. An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents. Br J Pharmacol. 1984 Jun;82(2):349–357. doi: 10.1111/j.1476-5381.1984.tb10769.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nattel S., Pedersen D. H., Zipes D. P. Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog. Cardiovasc Res. 1981 Feb;15(2):80–85. doi: 10.1093/cvr/15.2.80. [DOI] [PubMed] [Google Scholar]
  12. Wenger T. L., Browning D. J., Masterton C. E., Abou-Donia M. B., Harrell F. E., Jr, Bache R. J., Strauss H. C. Procainamide delivery to ischemic canine myocardium following rapid intravenous administration. Circ Res. 1980 Jun;46(6):789–795. doi: 10.1161/01.res.46.6.789. [DOI] [PubMed] [Google Scholar]
  13. Winslow E. Methods for the detection and assessment of antiarrhythmic activity. Pharmacol Ther. 1984;24(3):401–433. doi: 10.1016/0163-7258(84)90011-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES